Summit Therapeutics (NASDAQ: SMMT) has been one of the hottest stocks to own over the past 12 months, with its valuation ...

The NCI will lead the trial of the firm's Versamune MUC1 immunotherapy and its antibody-drug conjugate PDS01ADC.

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

The Trump administration has decided to withdraw its nominee to lead the U.S. Centers for Disease Control and Prevention (CDC ...

DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a ...

Kioxia Corporation has been named a Clarivate Top 100 Global Innovators 2025, an award given to the most innovative global companies by Clarivate Plc. This is the fourth time Kioxia has received this ...

February 19, 2025, the company was named an Advanced Partner under the X Ads Agency Certification Program by X Corp. Japan K.K. Among all certified advertising agencies, X Corp. Japan K.K. recognizes ...

The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.